Bisavenathramide analogues as Nrf2 inductors and neuroprotectors in in vitro models of oxidative stress and hyperphosphorylation
Entity
UAM. Departamento de FarmacologíaPublisher
MDPIDate
2021-06-10Citation
10.3390/antiox10060941
Antioxidants 10.6 (2021): 941
ISSN
2076-3921DOI
10.3390/antiox10060941Funded by
This research was funded by the Spanish ministry of Science, Innovation and Education (grant RTI2018-097662-B-I00 to J.C.M.), IS Carlos III co-financed by the European Regional Development funds (FEDER) (grants PI17/01700 and PI20/00433 to R.L.) and Comunidad Autónoma de Madrid (grants B2017/BMD-3813, J.C.M., and B2017/BMD-3827, R.L.). The APC were not fundedProject
Gobierno de España. RTI2018-097662-B-I00; Gobierno de España. PI17/01700; Gobierno de España. PI20/00433; Comunidad de Madrid. B2017/BMD-3827/NRF24AD-CM; Comunidad de Madrid. B2017/BMD-3813/ELA-MADRID-CMEditor's Version
https://doi.org/10.3390/antiox10060941Subjects
Bisavenanthramides; Keap1; Neurodegenerative diseases; Nrf2 regulation; Nrf2–ARE pathway; Oxidative stress; Farmacia; MedicinaRights
© 2021 by the authorsAbstract
Oxidative stress is crucial to the outbreak and advancement of neurodegenerative diseases and is a common factor to many of them. We describe the synthesis of a library of derivatives of the 4-arylmethylen-2-pyrrolin-5-one framework by sequential application of a three-component reaction of primary amines, β-dicarbonyl compounds, and α-haloketones and a Knoevenagel condensation. These compounds can be viewed as cyclic amides of caffeic and ferulic acids, and are also structurally related to the bisavenanthramide family of natural antioxidants. Most members of the library showed low cytotoxicity and good activity as inductors of Nrf2, a transcription factor that acts as the master regulator of the antioxidant response associated with activation of the antioxidant response element (ARE). Nrf2-dependent protein expression was also proved by the significant increase in the levels of the HMOX1 and NQO1 proteins. Some compounds exerted neuroprotective properties in oxidative stress situations, such as rotenone/oligomycin-induced toxicity, and also against protein hyperphosphorylation induced by the phosphatase inhibitor okadaic acid. Compound 3i, which can be considered a good candidate for further hit-to-lead development against neurodegenerative diseases due to its well-balanced multitarget profile, was further characterized by proving its ability to reduce phosphorylated Tau levels
Files in this item
Google Scholar:Cores, Ángel
-
Abril, Sheila
-
Michalska, Patrycja
-
Duarte, Pablo
-
Olives, Ana I.
-
Martín, M. Antonia
-
Villacampa, Mercedes
-
León, Rafael
-
Carlos Menéndez, J.
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties
Herrera-Arozamena, Clara; Estrada-Valencia, Martín; Pérez, Concepción; Lagartera, Laura; Morales-García, José A.; Pérez-Castillo, Ana; Franco-Gonzalez, Juan Felipe; Michalska, Patrycja; Duarte, Pablo; León, Rafael; López, Manuela G.; Mills, Alberto; Gago, Federico; García-Yagüe, Ángel Juan; Fernández-Ginés, Raquel; Cuadrado Pastor, Antonio; Rodríguez-Franco, María Isabel
2020-01-25 -
MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
Vera-Puente, Olga; Rodríguez-Antolín, Carlos; Salgado-Figueroa, Ana; Michalska, Patrycja; Pernia, Olga; Reid, Brett M.; Rosas, RocÍo; García-Guede, Álvaro; Sacristán, Silvia; Jiménez, Julia; Esteban-Rodríguez, Isabel; Martín, M. Elena; Sellers, Thomas A.; León, Rafael; González, VÍctor M.; De Castro, Javier; Ibáñez de Cáceres, Inmaculada
2018-06-17